Volume 14, Issue 4 (2012)                   mjms 2012, 14(4): 51-62 | Back to browse issues page

XML Persian Abstract Print

1- Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
2- Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
3- Department of Stem Cell Biology, Stem Cell Technology Research Center, Tehran, Iran
4- Department of Molecular Biology and Genetic Engineering, Stem Cell Technology Research Center, Tehran, Iran
Abstract:   (5822 Views)
Objective: Infection with herpes simplex virus type 1 induces viral latency in neuron trigeminal ganglions. The late associated transcript (LAT) is uniquely expressed in infected neural cells, however no coding protein associated with these transcripts has been identified in infected cells. It has been shown that six microRNAs transcribed from LAT have the capabilities to affect the cell signaling pathways, thus interfering in pathways such as those of cell differentiation and proliferation. Transforming growth factor beta (TGF-β) pathway is a critical pathway among cell signaling circuits. The Smad4 protein, as an important member of the TGF-β signaling pathway, mediates the connection between membrane receptors, cytoplasmic kinases, and nuclear transcription factors. Methods: This study bioinformatically and experimentally evaluated LAT microRNA expression and assessed microRNA targeting of Smad4 transcripts in human neuroblastoma cells by using real-time PCR. Results: Analysis of two different softwares results showed that the Smad4 gene was targeted by LAT-derived microRNAs at multiple sites. Over-expression of LAT microRNAs in BE2(c) cells caused reduction in Smad4 transcripts. Conclusion: The results of bioinformatical analysis with relative quantification of Smad4 transcripts and its downstream-related genes such as cyclinD, CDK2, and Myc showed that the LAT transcript could control Smad4 expression.
Full-Text [PDF 1306 kb]   (7118 Downloads)    
Article Type: Original Manuscipt | Subject: Medical Biotechnology|Virology
Received: 2011/10/13 | Accepted: 2011/12/21

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.